Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — you should not take two 2.5 mg Mounjaro doses together or on the same day. Each Mounjaro pen delivers a single weekly dose, and doubling up does not replicate the next strength. The 2.5 mg starting dose exists to settle your system, not as a stepping stone you can shortcut by stacking two pens. These are Prescription-Only Medicines; your prescriber decides when and whether your dose should change, based on how you're responding and tolerating treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks: "I've been on 2.5 mg for a month and nothing seems to be happening, can I just take two?" It's an understandable thought, and the frustration behind it is real. But the starter dose is designed the way it is for a specific reason. Tirzepatide activates both GIP and GLP-1 receptors, which slow gastric emptying and reduce appetite. Starting low gives your digestive system time to adapt to those changes before the therapeutic dose kicks in. Most of the meaningful weight-loss effect comes at higher doses (5 mg and above) which is exactly why the licensed schedule builds through them gradually. If you're wondering whether taking two doses of 2.5 mg Mounjaro would speed that process along, our prescribers explain in detail why the answer is no. Feeling impatient at 2.5 mg is not a sign the medicine isn't working; it's a sign the medicine is doing precisely what it was prescribed to do at this stage. You can read more about what to expect as treatment progresses on our Mounjaro overview page.
Mounjaro pens are not interchangeable building blocks. Each KwikPen delivers a precise, pre-filled volume at a calibrated concentration, the 2.5 mg and 5 mg versions are not the same pen with a different label. Injecting twice in one week, or twice in one day, would expose your body to a higher dose than your prescriber approved at a pace your system hasn't had the chance to adjust to. The most likely result is a sharp increase in gastrointestinal side effects: pronounced nausea, vomiting, and diarrhoea. Beyond discomfort, the concern is dehydration, which can put strain on the kidneys. There is also the question of injection-site reactions and the simple practical issue that you'd be depleting your supply ahead of schedule, leaving a gap before your next delivery. We cover the specific risks of taking two 2.5 mg Mounjaro shots on a dedicated page if you want the full clinical picture. If you didn't get what felt like a full dose for another reason (pen malfunction, for example) that's a different question, and one our team covers on a separate page about incomplete doses. The NHS tirzepatide guidance is clear: take the dose your prescriber has prescribed, once a week, no more.
The licensed schedule for Mounjaro runs through six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg. Typically, each step lasts around four weeks, though your prescriber may keep you at a particular dose longer if it's better tolerated or if you're still responding well at a lower level. The decision to move up isn't automatic, at nume we require clinical re-review before every repeat order, which means a prescriber checks how you're getting on before your next pen is dispatched. There are no auto-renewals, no assumptions. If you feel your current dose isn't right, the right route is to raise that in your aftercare review. You can reach our prescribing team through our contact page any day of the week. For a fuller picture of how the 5 mg step compares to the starter dose, our 5 mg Mounjaro page walks through what changes at that level. NICE's appraisal of tirzepatide, TA1026, sets out the clinical framework that informs how dose progression is managed in practice.
Some people consider doubling up partly because they've heard that the lower doses are less expensive and want to stretch out the cheaper pens. It's worth being honest about: private Mounjaro pricing does vary by dose, and that's a real consideration for many people. But using two pens at once wouldn't save money, it would burn through your supply twice as fast and, crucially, it would mean taking a dose your prescriber hasn't sanctioned. For context on how private pricing works across the dose range, our Mounjaro price comparison page sets out what's typically included and what to look for. At nume, the price covers the consultation, prescription, and next-working-day tracked delivery, no separate fees per item. What it never includes is an invitation to manage your own dose outside clinical guidance. If cost is genuinely a concern, talk to our prescribers; they're better placed to help than a doubled-up pen. There's also broader context on our weight-loss treatment overview for anyone still working out which route suits them.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.